| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 180.57B | 192.50B | 197.95B | 190.46B | 175.92B | 176.97B |
| Gross Profit | 20.08B | 30.89B | 38.30B | 42.33B | 37.64B | 42.14B |
| EBITDA | 18.74B | 24.10B | 30.32B | 34.34B | 33.22B | 30.35B |
| Net Income | -662.22M | 955.84M | 3.03B | 4.20B | 3.86B | 2.03B |
Balance Sheet | ||||||
| Total Assets | 164.71B | 172.04B | 168.72B | 173.38B | 180.84B | 193.70B |
| Cash, Cash Equivalents and Short-Term Investments | 25.54B | 33.90B | 31.42B | 37.53B | 41.27B | 48.45B |
| Total Debt | 8.64B | 8.95B | 13.44B | 20.59B | 22.47B | 20.61B |
| Total Liabilities | 86.47B | 93.56B | 89.34B | 94.44B | 105.96B | 120.11B |
| Stockholders Equity | 57.51B | 57.31B | 57.01B | 54.50B | 52.58B | 51.09B |
Cash Flow | ||||||
| Free Cash Flow | 16.50B | 19.16B | 15.43B | 12.43B | 4.46B | 14.41B |
| Operating Cash Flow | 17.48B | 29.15B | 24.25B | 18.65B | 12.90B | 26.01B |
| Investing Cash Flow | -7.23B | -10.99B | -9.37B | -7.86B | -7.77B | -11.54B |
| Financing Cash Flow | -8.01B | -15.63B | -21.28B | -14.68B | -12.14B | -16.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$258.31B | 9.90 | 18.03% | 1.95% | ― | ― | |
66 Neutral | HK$180.78B | 12.11 | 11.66% | 3.41% | 7.93% | -12.94% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | HK$12.82B | -14.89 | 0.22% | 4.98% | -6.72% | -130.82% | |
47 Neutral | HK$70.50B | -4.42 | -7.98% | 1.35% | -8.79% | -212.16% |